PFAS are endocrine-disrupting chemicals that interfere with hormonal systems governing female reproductive health. From menstrual cycle regulation to fertility, pregnancy outcomes, and menopause timing, PFAS have been implicated in a wide range of reproductive effects in women.
PFAS and Female Fertility
Several studies have examined associations between PFAS exposure and time-to-pregnancy — a validated measure of fertility. A Danish study of couples planning pregnancy found that women with higher PFAS blood levels had longer time-to-pregnancy and were more likely to be classified as subfertile. Similar findings have been reported from U.S. and European cohort studies.
PFAS may impair fertility through effects on ovarian function, menstrual cycle regularity, and hormonal balance. Animal studies have shown that PFAS reduce follicle numbers and alter estrogen production in the ovary, while human data suggest associations with irregular menstrual cycles and altered hormone levels including estradiol and follicle-stimulating hormone (FSH).
Pregnancy Complications
PFAS exposure during pregnancy has been associated with several adverse outcomes. Preeclampsia — a dangerous pregnancy complication involving high blood pressure — has been linked to higher PFAS levels in multiple studies. Preterm birth associations have also been reported, though results vary across studies.
Gestational diabetes risk appears elevated in women with higher PFAS exposure, consistent with PFAS effects on glucose metabolism and insulin signaling. Reduced birth weight and altered fetal growth patterns have also been observed in studies examining prenatal PFAS exposure.
Breastfeeding and PFAS Transfer
PFAS accumulate in breast milk and are transferred to nursing infants, which complicates breastfeeding decisions for women with high PFAS exposures. While breastfeeding provides substantial nutritional and immune benefits that are not easily replaced, PFAS transfer through breast milk represents a meaningful exposure pathway for infants.
Public health guidance generally continues to support breastfeeding even in PFAS-contaminated areas, given the well-established benefits. However, reducing maternal PFAS exposure before and during pregnancy — including through water filtration — can help minimize the PFAS burden in breast milk.
Menopause Timing
Early menopause is associated with increased risks of cardiovascular disease, osteoporosis, and cognitive decline. Research has found associations between higher PFAS levels and earlier menopause onset, suggesting that PFAS may accelerate ovarian aging. A study examining data from over 25,000 women found that those with higher PFAS exposure experienced menopause approximately 2 years earlier than less-exposed women.
Protecting Reproductive Health
Women planning pregnancy, currently pregnant, or breastfeeding have strong reasons to minimize PFAS exposure. High-quality water filtration — particularly reverse osmosis — removes PFAS from drinking water used for cooking and drinking, reducing one of the primary dietary sources of exposure. Testing household water for PFAS provides the information needed to make targeted filtration decisions.